SUMMA RX LABORATORIES INC
10QSB, EX-27, 2000-12-12
PHARMACEUTICAL PREPARATIONS
Previous: SUMMA RX LABORATORIES INC, 10QSB, 2000-12-12
Next: WRL SERIES FUND INC, PREM14C, 2000-12-12



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FORM 10-QSB
FOR THE SIX MONTHS ENDED OCTOBER 31, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FORM 10-QSB FOR THE SIX MONTHS ENDED OCTOBER 31, 2000.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          APR-30-2001
<PERIOD-START>                             MAY-01-2000
<PERIOD-END>                               OCT-31-2000
<CASH>                                       1,205,145
<SECURITIES>                                         0
<RECEIVABLES>                                  302,456
<ALLOWANCES>                                    98,729
<INVENTORY>                                    229,252
<CURRENT-ASSETS>                             1,759,122
<PP&E>                                       2,025,970
<DEPRECIATION>                                 800,376
<TOTAL-ASSETS>                               2,984,716
<CURRENT-LIABILITIES>                          854,716
<BONDS>                                              0
                                0
                                          0
<COMMON>                                        31,458
<OTHER-SE>                                   2,098,542
<TOTAL-LIABILITY-AND-EQUITY>                 2,984,716
<SALES>                                      1,447,526
<TOTAL-REVENUES>                             1,447,526
<CGS>                                        1,234,235
<TOTAL-COSTS>                                1,619,189
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                            (18,437)
<INCOME-PRETAX>                              (153,226)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (153,226)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 (153,226)
<EPS-BASIC>                                      (.05)
<EPS-DILUTED>                                    (.05)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission